B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME). Their anti-tumor functions include recognizing tumor-associated antigens, ...
CREATE Medicines, Inc. ("CREATE"), a clinical-stage biotechnology company pioneering in vivo CAR therapy, today announced new ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...
The use of next-generation sequencing (NGS) technologies to detect B-cell receptor (BCR) or T-cell receptor (TCR) clonotypes ...
A new study reveals how bacteria in the gut can help determine whether the amino acid asparagine from the diet will feed ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients with systemic lupus erythematosus who received ...
A groundbreaking phase 2 trial explores a novel, chemotherapy-free immunotherapy for relapsed indolent B-cell lymphomas, aiming to enhance patient outcomes.
Your immune system is your body’s built-in defense network, working nonstop to protect you from bacteria, viruses, and other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results